These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29359418)

  • 1. Effective shunt closure for pulmonary hypertension and liver dysfunction in congenital portosystemic venous shunt.
    Uike K; Nagata H; Hirata Y; Yamamura K; Terashi E; Matsuura T; Morihana E; Ohkubo K; Ishii K; Sakai Y; Taguchi T; Ohga S
    Pediatr Pulmonol; 2018 Apr; 53(4):505-511. PubMed ID: 29359418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter interventional treatment of congenital portosystemic venous shunts in childhood.
    Knirsch W; Benz DC; Bühr P; Quandt D; Weber R; Kellenberger C; Braegger CP; Kretschmar O
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1281-92. PubMed ID: 26715199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and therapeutic outcomes of pulmonary arterial hypertension secondary to congenital portosystemic shunts.
    Wu J; Lu Y; Zhao W; Shen J; Li F; Zhang H; Chen Q; Fu L
    Eur J Pediatr; 2021 Mar; 180(3):929-936. PubMed ID: 33011830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital extrahepatic portocaval malformation: Rare but potentially treatable cause of pulmonary hypertension.
    Bobhate P; Garg S; Sharma A; Roy D; Raut A; Pawar R; Karande T; Kulkarni S
    Indian Heart J; 2021; 73(1):99-103. PubMed ID: 33714417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Child with Prostaglandin I
    Sonoda Y; Yamamura K; Ishii K; Ohkubo K; Ihara K; Sakai Y; Ohga S
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):207-210. PubMed ID: 30325337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in patients with congenital portosystemic venous shunt: a previously unrecognized association.
    Ohno T; Muneuchi J; Ihara K; Yuge T; Kanaya Y; Yamaki S; Hara T
    Pediatrics; 2008 Apr; 121(4):e892-9. PubMed ID: 18362102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary survival outcomes of congenital systemic-to-pulmonary shunt in children with borderline pulmonary vascular resistant index compared to Eisenmenger syndrome.
    Chaiwangyen N; Vijarnsorn C; Chungsomprasong P; Chanthong P; Kanjanauthai S; Thammasate P; Pacharapakornpong T; Bositthipichet D; Sengsim J; Soongswang J; Tocharoenchok T; Nitiyarom E; Tantiwongkosri K; Subtaweesin T; Durongpisitkul K
    Sci Rep; 2024 Jul; 14(1):16867. PubMed ID: 39043775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6months of age.
    Bambul Heck P; Eicken A; Kasnar-Samprec J; Ewert P; Hager A
    Int J Cardiol; 2017 Feb; 228():313-318. PubMed ID: 27866021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Arterial Hypertension Associated with Congenital Portosystemic Shunts Treated with Transcatheter Embolization and Pulmonary Vasodilators.
    Sato H; Miura M; Yaoita N; Yamamoto S; Tatebe S; Aoki T; Satoh K; Ota H; Takase K; Sugimura K; Shimokawa H
    Intern Med; 2016; 55(17):2429-32. PubMed ID: 27580545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disorders in patients with congenital portosystemic shunts: 23 years of experience in a tertiary referral centre.
    Lambert V; Ladarre D; Fortas F; Durand P; Hervé P; Gonzales E; Guérin F; Savale L; McLin VA; Ackermann O; Franchi-Abella S;
    Arch Cardiovasc Dis; 2021 Mar; 114(3):221-231. PubMed ID: 33281106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staged transcatheter treatment of portal hypoplasia and congenital portosystemic shunts in children.
    Bruckheimer E; Dagan T; Atar E; Schwartz M; Kachko L; Superina R; Amir G; Shapiro R; Birk E
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1580-1585. PubMed ID: 23435744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study.
    Baiges A; Turon F; Simón-Talero M; Tasayco S; Bueno J; Zekrini K; Plessier A; Franchi-Abella S; Guerin F; Mukund A; Eapen CE; Goel A; Shyamkumar NK; Coenen S; De Gottardi A; Majumdar A; Onali S; Shukla A; Carrilho FJ; Nacif L; Primignani M; Tosetti G; La Mura V; Nevens F; Witters P; Tripathi D; Tellez L; Martínez J; Álvarez-Navascués C; Fraile López ML; Procopet B; Piscaglia F; de Koning B; Llop E; Romero-Cristobal M; Tjwa E; Monescillo-Francia A; Senzolo M; Perez-LaFuente M; Segarra A; Sarin SK; Hernández-Gea V; Patch D; Laleman W; Hartog H; Valla D; Genescà J; García-Pagán JC;
    Hepatology; 2020 Feb; 71(2):658-669. PubMed ID: 31211875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaching atrial septal defects in pulmonary hypertension.
    Schwerzmann M; Pfammatter JP
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):693-701. PubMed ID: 25982879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension-A Case Study Series.
    Hlavata T; Kaldararova M; Klauco F; Drangova E; Reptova A; Simkova I
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295644
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case report of a ventricular septal defect with congenital portosystemic venous shunt].
    Yoshino H; Kayashima K; Yamamoto K; Okada H; Kataoka K; Kinoshita Y; Ikezaki A
    Masui; 2010 Nov; 59(11):1432-4. PubMed ID: 21077317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balloon-occluded retrograde transvenous obliteration for treatment of congenital intrahepatic portosystemic venous shunt: A case report.
    Lin S; Xu Z; Fan Z; Zhang W; Yang G; Qian S; Liu R
    J Interv Med; 2023 Feb; 6(1):49-51. PubMed ID: 37180373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.